26108-75-8

Basic information

• Product Name: 1,3,4,6-TETRA-O-ACETYL-2-AMINO-2-DESOXY-BETA-D-GLUCOPYRANOSE HYDROCHLORIDE
• Synonyms: 1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-alpha-D-glucopyranose hydrochloride;1,3,4,6-TETRA-O-ACETYL-2-AMINO-2-DEOXY-B-D-GLUCOPYRANOSE HCL;1,3,4,6-TETRA-O-ACETYL-2-AMINO-2-DEOXY-BETA-D-GLUCOPYRANOSE HYDROCHLORIDE;1,3,4,6-TETRA-O-ACETYL-2-AMINO-2-DESOXY-BETA-D-GLUCOPYRANOSE HYDROCHLORIDE;1,3,4,6-Tetra-O-acetyl-2-amino-2-desoxy-beta-D-glucopyranoseHCl;1,3,4,6-Tetra-O-acetyl-2-amino-2-desoxy-beta-D-glucopyranose hydrochloride 98%;1,3,4,6-Tetra-O-acetyl-2-amino-2-desoxy-D-;1,3,4,6,-Tetra-O-Acetyl-β-D-Glucosamine
• CAS NO: 26108-75-8
• Molecular Formula: C₁₄H₂₁NO₉
• Molecular Weight: 383.78
• Mol File: 26108-75-8.mol
• Article Data: 20

Chemical Properties

• Melting Point: 225°C
• Boiling Point: 429.5oC at 760 mmHg
• Flash Point: 158.3oC
• Appearance: /
• Density: 1.30±0.1 g/cm3(Predicted)
• Vapor Pressure: 1.39E-07mmHg at 25°C
• PKA: 7.57±0.70(Predicted)
• CAS DataBase Reference: 1,3,4,6-TETRA-O-ACETYL-2-AMINO-2-DESOXY-BETA-D-GLUCOPYRANOSE HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,4,6-TETRA-O-ACETYL-2-AMINO-2-DESOXY-BETA-D-GLUCOPYRANOSE HYDROCHLORIDE(26108-75-8)
• EPA Substance Registry System: 1,3,4,6-TETRA-O-ACETYL-2-AMINO-2-DESOXY-BETA-D-GLUCOPYRANOSE HYDROCHLORIDE(26108-75-8)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 26108-75-8(Hazardous Substances Data)

Usage

General Description

1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-beta-D-glucopyranose hydrochloride is a chemical compound mainly used in various scientific and research applications. 1,3,4,6-TETRA-O-ACETYL-2-AMINO-2-DESOXY-BETA-D-GLUCOPYRANOSE HYDROCHLORIDE, often also known simply as ‘2-amino-2-deoxy-beta-D-glucose hydrochloride acetate’, belongs to the class of organic compounds known as O-glycosyl compounds. These compounds contain a glycosyl moiety directly linked to a derivative of an alcohol via a oxygen atom. The compound is commonly used in laboratories and in the production of various products, although it has no broadly known commercial applications.

InChI:InChI=1/C14H21NO9.ClH/c1-6(16)20-5-10-12(21-7(2)17)13(22-8(3)18)11(15)14(24-10)23-9(4)19;/h10-14H,5,15H2,1-4H3;1H

Upstream product

• 52162-39-7 2-(benzylidene)amino-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose 
• 80321-89-7 1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-β-D-glucopyranose 
• 130005-73-1 3,4,6-tri-O-acetyl-2-deoxy-2-p-methoxybenzylideneamino-β-D-glucopyranose 
• 14131-63-6 D-glucosamine hydrochloride 
• 1078691-95-8 (+)-D-glucosamine hydrochloride 
• 108-24-7 acetic anhydride 
• 51471-40-0 6-(hydroxymethyl)-3-[4-methoxybenzylideneamino]tetrahydropyran-2,4,5-triol 
• 14131-62-5 D-glucosamine hydrochloride 
• 90176-39-9 2-benzylideneamino-2-deoxy-β-D-glucopyranose 
• 90-76-6 2-deoxy-2-amino glucose 
• 51471-40-0 2--2-deoxy-D-glucopyranose 
• 5432-46-2 1,3,4,6-tetra-O-acetyl-D-glucosamine hydrochloride 
• 7647-01-0 hydrogenchloride 
• 67-64-1 acetone 

Downstream Products

• 106117-37-7 tetra-O-acetyl-2-[(N-benzyloxycarbonyl-α-L-glutamyl)-amino]-2-deoxy-β-D-glucopyranose 
• 10022-13-6 1,3,4,6-tetra-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranose 
• 129778-10-5 2-benzylsuccinamido 2-deoxy 1,3,4,6-tetra O-acetyl β-D-glucose 
• 137037-17-3 N-(2-chloroethoxysulfonyl), N'-<(β-D)-O-1',3',4',6'-tetraacetyl-2'-desoxyglucos-2-yl> uree 
• 136963-58-1 N-(2-chloroethoxysulfonyl), N'-(1-phenylethyl) uree 
• 134176-56-0 1,3,4,6-tetra-O-acetyl-2-(3-benzoylthioureido)-2-deoxy-β-D-glucopyranose 
• 10385-49-6 1,2,4,6-tetra-O-acetyl-2-benzamido-2-deoxy-β-D-glucopyranose 
• 10551-58-3 5-acetoxymethyl-2-furaldehyde 
• 604-69-3 β-D-glucose pentaacetate 
• 604-68-2 α-D-glucopyranose peracetylate 
• 83-87-4 D-Mannose pentaacetate 
• 3947-62-4 2,3,4,5-tetra-O-acetyl-D-glucopyranose 
• 50710-97-9 3,4,6-tri-O-acetyl-2,5-anhydro-aldehydro-D-mannose 
• 82823-61-8 C₂₄H₂₉N₅O₉ 

Relevant articles and documents

1,8-NAPHTHYRIDINE GLUCOSAMINE DERIVATIVES, THEIR USE IN THE TREATMENT OF MICROBIAL INFECTIONS, AND A METHOD FOR PREPARATION

The present disclosure provides a compound of Formula (I) or any pharmaceutically acceptable salt thereof for use in treating a microbial infection in a subject, a method for preparing the same, and a pharmaceutical composition thereof: (I) wherein R

GLYCOSYLATED 3-SUBSTITUTED FLUOROQUINOLONE DERIVATIVES, PREPARATION METHODS THEREOF, AND THEIR USE IN THE TREATMENT OF ANTIMICROBIAL INFECTIONS

The present disclosure relates to 3-substituted fluoroquinolone derivatives, and more particularly to glycosylated 3-substitutred fluoroquinolone derivatives, methods of preparation thereof, and uses thereof for treating microbial infections.

Design, synthesis, and biological evaluation of 1,8-naphthyridine glucosamine conjugates as antimicrobial agents

In the quest for discovering potent antimicrobial agents with lower toxicity, we envisioned the design and synthesis of nalidixic acid-D-(+)-glucosamine conjugates. The novel compounds were synthesized and evaluated for their in vitro antimicrobial activi